Mar. 6, 2015-- BioLineRx , a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, announced today that its Chief Executive Officer, Kinneret Savitsky, Ph.D., and its Chief Financial and Operating Officer, Philip Serlin, will be presenting at the 27th Annual Roth Conference being held at the Ritz Carlton in Dana Point, CA. The BioLineRx presentation is scheduled to start at 10:00 a.m. PDT on Tuesday, March 10, 2015.
http://ift.tt/1x0NXAH
http://ift.tt/1x0NXAH
No comments:
Post a Comment